A. Clemens

First name
Last name
Gallagher, A. M., Setakis, E., Plumb, J. M., Clemens, A., & van Staa, T. P. (2011). Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost. http://doi.org/10.1160/th11-05-0353
Gallagher, A. M., de Vries, F., Plumb, J. M., Hass, B., Clemens, A., & van Staa, T. P. (2012). Quality of INR control and outcomes following venous thromboembolism. Clin Appl Thromb Hemost. http://doi.org/10.1177/1076029611426139
Lee, S., Monz, B. U., Clemens, A., Brueckmann, M., & . Y. Lip, G. (2012). Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database. BMJ Open. http://doi.org/10.1136/bmjopen-2012-001768
Gallagher, A. M., van Staa, T. P., Murray-Thomas, T., Schoof, N., Clemens, A., Ackermann, D., & Bartels, D. B. (2014). Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes. BMJ Open. http://doi.org/10.1136/bmjopen-2013-003839
Stolz, D., Kostikas, K., Loefroth, E., Fogel, R., Clemens, A., Gutzwiller, F. S., et al. (2017). Gender differences in COPD exacerbations: Analysis from the CPRD database. Thorax.
Stolz, D., Kostikas, K., Loefroth, E., Fogel, R., Gutzwiller, F. S., Conti, V., et al. (2019). Differences in COPD exacerbation risk between women and men: analysis from the UK Clinical Practice Research Datalink data. Chest. http://doi.org/10.1016/j.chest.2019.04.107
Kostikas, K., Price, D., Gutzwiller, F. S., Jones, B., Loefroth, E., Clemens, A., et al. (2020). Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database. Int J Chron Obstruct Pulmon Dis. http://doi.org/10.2147/copd.s255414